NeurologyLive® Mind Moments®

138 Épisodes

1. 124: Therapeutic Updates and Progress in Treating Becker Muscular Dystrophy

   Publié: 20/09/2024
2. 123: Previewing Cleveland Clinic's Epilepsy Summit

   Publié: 06/09/2024
3. 122: RNA Therapeutics, Mivelsiran, and Treating Alzheimer Disease

   Publié: 23/08/2024
4. 121: Understanding the Potential Cardiovascular Benefits of Low-Sodium Oxybate

   Publié: 09/08/2024
5. 115: Expanding Access to Ublituximab and AntiCD20s for Multiple Sclerosis

   Publié: 31/07/2024
6. 120: Improving Gait in Multiple Sclerosis Through the Neural Sleeve

   Publié: 26/07/2024
7. 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease

   Publié: 12/07/2024
8. Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease

   Publié: 09/07/2024
9. 118: Gaining Patient Perspectives on Impact of Narcolepsy

   Publié: 28/06/2024
10. 117: 2024 Consortium of Multiple Sclerosis Centers Annual Meeting Highlights

    Publié: 14/06/2024
11. 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas

    Publié: 31/05/2024
12. 114: Phase 3 PHOENIX Study, AMX0035, and Amylyx's Future Drug Development

    Publié: 03/05/2024
13. Special Episode: FDA Approval of Diazepam Buccal Film for Pediatric Seizures

    Publié: 01/05/2024
14. 113: Lessons Learned in Alzheimer Drug Development

    Publié: 19/04/2024
15. 112: Exploring Dimethyl Fumarate to Treat Friedreich Ataxia

    Publié: 05/04/2024
16. Special Episode: FDA Approval of Givinostat for Duchenne Muscular Dystrophy

    Publié: 29/03/2024
17. 111: Reviewing ACTRIMS 2024

    Publié: 22/03/2024
18. 110: Differential Diagnosis of Sleep Disorders and Hypersomnias

    Publié: 08/03/2024
19. 109: AB126, Exosomes, and Cerebroprotection for Stroke

    Publié: 23/02/2024
20. 108: Advancing the Genetic Pool of Parkinson Disease

    Publié: 09/02/2024